Floatz logo

Calcium folinate pentahydrate

Extrahepatic Bile Duct Cancer

Lisata Therapeutics, Inc.Small moleculePhase 2Active
BB
70/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
55/ 100
Competitive Position
95/ 100

Competitive context

4 Active assets in the Extrahepatic Bile Duct Cancer cohort.

Asset / SponsorPhaseRating
Eloxatin
Lisata Therapeutics, Inc.
Phase 3BBB
FLUOROURACILUM
Lisata Therapeutics, Inc.
Phase 2BBB
Capecitabine
National Cancer Institute (NCI)
Phase 3BB
Irinotecan
AIO-Studien-gGmbH
Phase 2BB
Carboplatin
University of Nebraska
Phase 1/2B

View all 26 →

Same molecule, other indications

Calcium folinate pentahydrate is also rated in:

Advanced KRAS Positive Metastatic Colorectal CancerDormant
BBB
Indicative ·
78 / 100
View asset →
Recurrent Pancreatic CarcinomaDormant
BBB
Indicative ·
78 / 100
View asset →
Stage IV Colon CancerDormant
BBB
Indicative ·
77 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →